SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-300184
Filing Date
2021-10-15
Accepted
2021-10-15 17:25:36
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B4 d111280d424b4.htm 424B4 1497201
2 GRAPHIC g111280g13a26.jpg GRAPHIC 128691
3 GRAPHIC g111280g19z56.jpg GRAPHIC 119660
4 GRAPHIC g111280g22b02.jpg GRAPHIC 93295
5 GRAPHIC g111280g22c03.jpg GRAPHIC 59931
6 GRAPHIC g111280g22d04.jpg GRAPHIC 47334
7 GRAPHIC g111280g22f06.jpg GRAPHIC 70013
8 GRAPHIC g111280g36z36.jpg GRAPHIC 125676
9 GRAPHIC g111280g45c49.jpg GRAPHIC 54760
10 GRAPHIC g111280g72l45.jpg GRAPHIC 124475
11 GRAPHIC g111280g89a09.jpg GRAPHIC 46421
  Complete submission text file 0001193125-21-300184.txt   2657640
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B4 | Act: 33 | File No.: 333-259503 | Film No.: 211326818
SIC: 2836 Biological Products, (No Diagnostic Substances)